Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis
Conditions
- Hypercholesterolemia
- Coronary Heart Disease
Interventions
- DRUG: Mipomersen
- DRUG: Placebo
Sponsor
Kastle Therapeutics, LLC
Collaborators